Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis
Rawshani, A. et al. Mortality and cardiovascular disease in Type 1 and Type 2 diabetes. Nw Eng. J. Med. 376, 1407–1418 (2017).
Google Scholar
Pearson-Stuttard, J. et al. Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrin. 9, 165–173 (2021).
Google Scholar
Nathan, D. M. et al. Glycemia Reduction in Type 2 Diabetes – Glycemic Outcomes. N Engl J Med 387, 1063–1074 (2022).
Google Scholar
I. D. F. Diabetes Atlas. Diabetes around the world in 2021, (2021).
van Dieren, S. et al. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with Type 2 diabetes. Diabetologia 54, 264–270 (2011).
Google Scholar
Szymonifka, J. et al. Cardiovascular disease risk prediction for people with type 2 diabetes in a population-based cohort and in electronic health record data. JAMIA Open 3, 583–592 (2020).
Google Scholar
Ho, J. C. et al. Evaluation of available risk scores to predict multiple cardiovascular complications for patients with type 2 diabetes mellitus using electronic health records. Comp. Methods Prog. Biomed. Update 3, 100087 (2023).
Google Scholar
Chung, W. K. et al. Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the study of diabetes (EASD). Diabetes Care 43, 1617–1635 (2020).
Google Scholar
Nolan, J. J. et al. ADA/EASD precision medicine in diabetes initiative: an international perspective and future vision for precision medicine in diabetes. Diabetes Care 45, 261–266 (2022).
Google Scholar
Tobias, D. K. et al. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nat. Med. 29, 2438–2457 (2023).
Google Scholar
Damen, J. A. et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ 353, i2416 (2016).
Google Scholar
Zhiting, G. et al. Cardiovascular disease risk prediction models in the Chinese population- a systematic review and meta-analysis. BMC Public Health 22, 1608 (2022).
Google Scholar
Damen, J. A. et al. Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis. BMC Med. 17, 109 (2019).
Google Scholar
Romero-Cabrera, J. L., Ankeny, J., Fernández-Montero, A., Kales, S. N. & Smith, D. L. A systematic review and meta-analysis of advanced biomarkers for predicting incident cardiovascular disease among asymptomatic middle-aged adults. Int. J. Mol. Sci. 23, 13540 (2022).
Google Scholar
van Holten, T. C. et al. Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses. PLoS One 8, e62080 (2013).
Google Scholar
Guasti, L. et al. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis. Intern. Emerg. Med. 16, 201–207 (2021).
Google Scholar
Rienks, J., Barbaresko, J. & Nöthlings, U. Association of polyphenol biomarkers with cardiovascular disease and mortality risk: a systematic review and meta-analysis of observational studies. Nutrients 9, 415 (2017).
Google Scholar
Gohel, V., Jones, J. A. & Wehler, C. J. Salivary biomarkers and cardiovascular disease: a systematic review. Clin. Chem. Lab Med. 56, 1432–1442 (2018).
Google Scholar
Kanbay, M. et al. Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis. Int. Urol. Nephrol. 48, 2029–2042 (2016).
Google Scholar
Heianza, Y., Ma, W., Manson, J. E., Rexrode, K. M. & Qi, L. Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies. J. Am. Heart Assoc. 6, e004947 (2017).
Google Scholar
Wallace, T. C., Slavin, M. & Frankenfeld, C. L. Systematic review of anthocyanins and markers of cardiovascular disease. Nutrients 8, 32 (2016).
Google Scholar
Emadian, A., Andrews, R. C., England, C. Y., Wallace, V. & Thompson, J. L. The effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groups. Br. J. Nutr. 114, 1656–1666 (2015).
Google Scholar
Yun, H., Noh, N. I. & Lee, E. Y. Genetic risk scores used in cardiovascular disease prediction models: a systematic review. Rev. Cardiovasc. Med. 23, 8 (2022).
Google Scholar
Jeong, E. G. et al. Depth and combined infection is important predictor of lower extremity amputations in hospitalized diabetic foot ulcer patients. Korean J. Intern Med. 33, 952–960 (2018).
Google Scholar
Lin, J. S. et al. Nontraditional risk factors in cardiovascular disease risk assessment: updated evidence report and systematic review for the US preventive services task force. Jama 320, 281–297 (2018).
Google Scholar
Hlatky, M. A. et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 119, 2408–2416 (2009).
Google Scholar
Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).
Google Scholar
Wells GA, S. B., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
Viechtbauer, W. Conducting meta-analyses in R with the metafor Package. J. Stat. Soft. 36, 1–48 (2010).
Google Scholar
Owens, D. K. et al. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions–agency for healthcare research and quality and the effective health-care program. J. Clin. Epidemiol. 63, 513–523 (2010).
Google Scholar
Aromataris E. et al. JBI Manual for Evidence Synthesis. JBI, (2020).
Aboyans, V. et al. The prognosis of diabetic patients with high ankle-brachial index depends on the coexistence of occlusive peripheral artery disease. J. Vasc. Surg. 53, 984–991 (2011).
Google Scholar
Abu-Lebdeh, H. S., Hodge, D. O. & Nguyen, T. T. Predictors of macrovascular disease in patients with Type 2 diabetes mellitus. Mayo Clin. Proc. 76, 707–712 (2001).
Google Scholar
Afarideh, M. et al. Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in Type 2 diabetes. Atherosclerosis 254, 42–51 (2016).
Google Scholar
Afsharian, S. et al. Risk factors for cardiovascular disease and mortality events in adults with Type 2 diabetes- a 10-year follow-up: Tehran lipid and glucose study. Diabetes Metab. Res. Rev. 32, 596–606 (2016).
Google Scholar
Alele, J. D., Luttrell, L. M., Hollis, B. W., Luttrell, D. K. & Hunt, K. J. Relationship between vitamin D status and incidence of vascular events in the Veterans Affairs Diabetes Trial. Atherosclerosis 228, 502–507 (2013).
Google Scholar
Alkhalaf, A. et al. Sex specific association between carnosinase gene CNDP1 and cardiovascular mortality in patients with Type 2 diabetes (ZODIAC-22). J. Nephrol. 28, 201–207 (2015).
Google Scholar
Anand, D. V., Lahiri, A., Lim, E., Hopkins, D. & Corder, R. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated Type 2 diabetic subjects. J. Am. Coll. Cardiol. 47, 1850–1857 (2006).
Google Scholar
Anand, D. V. et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur. Heart J. 27, 713–721 (2006).
Google Scholar
Anavekar, N. S. et al. Predictors of cardiovascular events in patients with Type 2 diabetic nephropathy and hypertension: a case for albuminuria. Kidney Int Suppl, 66 S50-55 (2004).
Angiolillo, D. J. et al. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 50, 1541–1547 (2007).
Google Scholar
Anyanwagu, U., Donnelly, R. & Idris, I. Albuminuria regression and all-cause mortality among insulin-treated patients with Type 2 Diabetes: analysis of a large UK primary care Cohort. Am. J. Nephrol. 49, 146–155 (2019).
Google Scholar
Apperloo, E. M., Pena, M. J., de Zeeuw, D., Denig, P. & Heerspink, H. J. L. Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with Type 2 diabetes: a primary care cohort study. Diabetes Obes. Metab. 20, 1377–1383 (2018).
Google Scholar
Araki, S. et al. Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy. Diabetes Care 36, 1248–1253 (2013).
Google Scholar
Avogaro, A. et al. Incidence of coronary heart disease in Type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care 30, 1241–1247 (2007).
Google Scholar
Azab, B., Chainani, V., Shah, N. & McGinn, J. T. Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population: a 4-year follow-up study. Angiology 64, 456–465 (2013).
Google Scholar
Azevedo, M. J. et al. Value of diagnostic tools for myocardial ischemia used in routine clinical practice to predict cardiac events in patients with type 2 diabetes mellitus: a prospective study. Arq. Bras. Endocrinol. Metab. 50, 46–52 (2006).
Google Scholar
Bacci, S. et al. The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients. Diabetes 60, 1000–1007 (2011).
Google Scholar
Backhaus, S. J. et al. Cardiac magnetic resonance myocardial feature tracking for optimized risk assessment after acute myocardial infarction in patients with Type 2 Diabetes. Diabetes 69, 1540–1548 (2020).
Google Scholar
Basu, S. et al. Validation of risk Equations for complications of Type 2 diabetes (RECODe) using individual participant data from diverse longitudinal Cohorts in the U.S. Diabetes Care 41, 586–595 (2018).
Google Scholar
Basu, S., Sussman, J. B., Berkowitz, S. A., Hayward, R. A. & Yudkin, J. S. Development and validation of risk equations for complications Of Type 2 diabetes (RECODe) using individual participant data from randomised trials. Lancet Diabetes Endocrinol. 5, 788–798 (2017).
Google Scholar
Bates, R. E. et al. Impact of stress testing for coronary artery disease screening in asymptomatic patients with diabetes mellitus: a community-based study in olmsted county, Minnesota. Mayo Clin. Proc. 91, 1535–1544 (2016).
Google Scholar
Beaney, K. E. et al. Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids. Cardiovasc. Diabetol. 15, 115 (2016).
Google Scholar
Beilin, J., Stanton, K. G., McCann, V. J., Knuiman, M. W. & Divitini, M. L. Microalbuminuria in Type 2 diabetes: an independent predictor of cardiovascular mortality. Aust. N Z J. Med. 26, 519–525 (1996).
Google Scholar
Bell, K. J. L. et al. Prognostic impact of systolic blood pressure variability in people with diabetes. PLoS One 13, e0194084 (2018).
Google Scholar
Berkelmans, G. F. N. et al. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500,000 patients with Type 2 diabetes mellitus. Eur Heart J 40, 2899–2906 (2019).
Google Scholar
Bernard, S. et al. Relation between XbA1 apolipoprotein B gene polymorphism and cardiovascular risk in a Type 2 diabetic cohort. Atherosclerosis 175, 177–181 (2004).
Google Scholar
Bernard, S. et al. Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic Type 2 diabetic subjects. Diabetes Care 28, 1158–1162 (2005).
Google Scholar
Bianco, H. T. et al. Relevance of target-organ lesions as predictors of mortality in patients with diabetes mellitus. Arq Bras Cardiol 103, 272–281 (2014).
Google Scholar
Biscetti, F. et al. Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study. Cardiovasc. Diabetol. 19, 170 (2020).
Google Scholar
Bonito, B., Silva, A. P., Rato, F., Santos, N. & Neves, P. L. Resistin as a predictor of cardiovascular hospital admissions and renal deterioration in diabetic patients with chronic kidney disease. J. Diabetes Complications 33, 107422 (2019).
Google Scholar
Bosevski, M., Borozanov, V., Tosev, S. & Georgievska-Ismail, L. Is assessment of peripheral endothelial dysfunction useful tool for risk stratification of Type 2 diabetic patients with manifested coronary artery disease? Int. J. Cardiol. 131, 290–292 (2009).
Google Scholar
Bouchi, R. et al. Fluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with Type 2 diabetes. J. Diabetes Invest. 3, 148–155 (2012).
Google Scholar
Brownrigg, J. R. et al. Microvascular disease and risk of cardiovascular events among individuals with Type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol 4, 588–597 (2016).
Google Scholar
Bruce, D. G., Davis, W. A., Starkstein, S. E. & Davis, T. M. A prospective study of depression and mortality in patients with Type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 48, 2532–2539 (2005).
Google Scholar
Bruno, G., Barutta, F., Landi, A., Cavallo Perin, P. & Gruden, G. NT-proBNP linking low-moderately impaired renal function and cardiovascular mortality in diabetic patients: the population-based Casale Monferrato Study. PLoS One 9, e114855 (2014).
Google Scholar
Bruno, G. et al. N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study. Diabetes Care 36, 2677–2682 (2013).
Google Scholar
Bruno, G. et al. Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in Type 2 diabetes: the Casale Monferrato Study. Diabetologia 48, 427–434 (2005).
Google Scholar
Bruno, G. et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in Type 2 diabetes: the Casale Monferrato Study. Diabetes Care 27, 2689–2694 (2004).
Google Scholar
Burgess, D. C. et al. Incidence and predictors of silent myocardial infarction in Type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Eur. Heart J. 31, 92–99 (2010).
Google Scholar
Busch, M. et al. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension. Am. J. Kidney Dis. 48, 571–579 (2006).
Google Scholar
Böger, C. A. et al. RANTES gene polymorphisms predict all-cause and cardiac mortality in Type 2 diabetes mellitus hemodialysis patients. Atherosclerosis 183, 121–129 (2005).
Google Scholar
Cardona, A. et al. Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis. BMJ Open Diabetes Res Care 7, e000718 (2019).
Google Scholar
Cardoso, C. R., Ferreira, M. T., Leite, N. C. & Salles, G. F. Prognostic impact of aortic stiffness in high-risk Type 2 diabetic patients: the Rio deJaneiro Type 2 Diabetes Cohort Study. Diabetes Care 36, 3772–3778 (2013).
Google Scholar
Cardoso, C. R., Leite, N. C. & Salles, G. F. Prognostic importance of C-Reactive protein in high cardiovascular risk patients with Type 2 diabetes mellitus: the Rio de Janeiro Type 2 diabetes Cohort Study. J. Am. Heart Assoc. 5, e004554 (2016).
Google Scholar
Cardoso, C. R., Salles, G. F. & Deccache, W. Prognostic value of QT interval parameters in Type 2 diabetes mellitus: results of a long-term follow-up prospective study. J. Diabetes Complications 17, 169–178 (2003).
Google Scholar
Cardoso, C. R. L., Leite, N. C., Moram, C. B. M. & Salles, G. F. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with Type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study. Cardiovasc. Diabetol. 17, 33 (2018).
Google Scholar
Cardoso, C. R. L., Leite, N. C. & Salles, G. F. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study. Cardiovasc. Diabetol. 19, 50 (2020).
Google Scholar
Cardoso, C. R. L., Salles, G. C., Leite, N. C. & Salles, G. F. Prognostic impact of carotid intima-media thickness and carotid plaques on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro Type 2 diabetes cohort study. Cardiovasc. Diabetol. 18, 2 (2019).
Google Scholar
Carlsson, A. C. et al. Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach. Ups J. Med. Sci. 125, 37–43 (2020).
Google Scholar
Carlsson, A. C. et al. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in Type 2 diabetes. Cardiovasc. Diabetol. 15, 40 (2016).
Google Scholar
Carnethon, M. R. et al. Association of weight status with mortality in adults with incident diabetes. JAMA 308, 581–590 (2012).
Google Scholar
Casiglia, E. et al. Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects. Eur. J. Epidemiol. 16, 677–684 (2000).
Google Scholar
Cavalot, F. et al. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in Type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study. Diabetes Care 34, 2237–2243 (2011).
Google Scholar
Cavalot, F. et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in Type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J. Clin. Endocrinol. Metab. 91, 813–819 (2006).
Google Scholar
Cea Soriano, L., Johansson, S., Stefansson, B. & Rodríguez, L. A. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with Type 2 diabetes: associations with renal function and cardiovascular risk factors. Cardiovasc. Diabetol. 14, 38 (2015).
Google Scholar
Cederholm, J. et al. Risk prediction of cardiovascular disease in Type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care 31, 2038–2043 (2008).
Google Scholar
Celis-Morales, C. A. et al. Associations between diabetes and both cardiovascular disease and all-cause mortality are modified by grip strength: evidence from UK Biobank, a prospective population-based Cohort study. Diabetes Care 40, 1710–1718 (2017).
Google Scholar
Ceriello, A. et al. Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial. Cardiovasc. Diabetol. 19, 176 (2020).
Google Scholar
Cha, S. A. et al. Time- and frequency-domain measures of heart rate variability predict cardiovascular outcome in patients with Type 2 diabetes. Diabetes Res. Clin. Pract. 143, 159–169 (2018).
Google Scholar
Cha, S. A. et al. Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with Type 2 Diabetes. PLoS One 11, e0164807 (2016).
Google Scholar
Chacko, K. M. et al. Heart rate recovery predicts mortality and cardiovascular events in patients with type 2 diabetes. Med. Sci. Sports Exerc. 40, 288–295 (2008).
Google Scholar
Chan, J. C. et al. Premature mortality and comorbidities in young-onset diabetes: a 7-year prospective analysis. Am. J. Med. 127, 616–624 (2014).
Google Scholar
Chang, C. W. et al. The first harmonic of radial pulse as an early predictor of silent coronary artery disease and adverse cardiac events in Type 2 diabetic patients. Cardiol. Res. Pract. 2018, 5128626 (2018).
Google Scholar
Chang, L. H. et al. The ankle brachial index exhibits better association of cardiovascular prognosis than non-high-density lipoprotein cholesterol in Type 2 diabetes. Am. J. Med. Sci. 351, 492–498 (2016).
Google Scholar
Chang, L. H. et al. Upstroke time per cardiac cycle is associated with cardiovascular prognosis in Type 2 diabetes. Endocr. Pract. 25, 1109–1116 (2019).
Google Scholar
Charlton-Menys, V. et al. Apolipoproteins, cardiovascular risk and statin response in Type 2 diabetes: the collaborative atorvastatin diabetes study (CARDS). Diabetologia 52, 218–225 (2009).
Google Scholar
Chen, H. S. et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients. Diabet. Med. 24, 1336–1344 (2007).
Google Scholar
Chen, S. et al. The long-term effectiveness of metabolic control on cardiovascular disease in patients with diabetes in a real-world health care setting – A prospective diabetes management study. Prim. Care Diabetes 14, 274–281 (2020).
Google Scholar
Cheng, F. et al. Shortened relative leukocyte telomere length is associated with prevalent and incident cardiovascular complications in Type 2 diabetes: analysis from the Hong Kong diabetes register. Diabetes Care 43, 2257–2265 (2020).
Google Scholar
Christensen, P. K. et al. QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scand J. Clin. Lab Invest. 60, 323–332 (2000).
Google Scholar
Christiansen, M. S., Hommel, E., Magid, E. & Feldt-Rasmussen, B. Orosomucoid in urine predicts cardiovascular and over-all mortality in patients with Type II diabetes. Diabetologia 45, 115–120 (2002).
Google Scholar
Christiansen, M. S., Hommel, E., Magid, E. & Feldt-Rasmussen, B. Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with Type 2 diabetes at five years of follow-up. Diabetologia 48, 386–393 (2005).
Google Scholar
Church, E. et al. Relationship between estimated glomerular filtration rate and incident cardiovascular disease in an ethnically diverse primary care cohort. N Z Med. J. 132, 11–26 (2019).
Google Scholar
Chyun, D. A. et al. Autonomic dysfunction independently predicts poor cardiovascular outcomes in asymptomatic individuals with Type 2 diabetes in the DIAD study. SAGE Open Med. 3, 2050312114568476 (2015).
Google Scholar
Cioffi, G. et al. Usefulness of subclinical left ventricular midwall dysfunction to predict cardiovascular mortality in patients with Type 2 diabetes mellitus. Am. J. Cardiol. 113, 1409–1414 (2014).
Google Scholar
Clarke, P. M. et al. A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 47, 1747–1759 (2004).
Google Scholar
Clarke, P. M. et al. Using the EQ-5D index score as a predictor of outcomes in patients with Type 2 diabetes. Med. Care 47, 61–68 (2009).
Google Scholar
Cockcroft, J. R. et al. Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus. Am. J. Hypertens. 18, 1463–1467 (2005).
Google Scholar
Colombo, M. et al. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in Type 2 diabetes. Atherosclerosis 274, 182–190 (2018).
Google Scholar
Cortigiani, L. et al. Prognostic meaning of coronary microvascular disease in type 2 diabetes mellitus: a transthoracic Doppler echocardiographic study. J. Am. Soc. Echocardiogr. 27, 742–748 (2014).
Google Scholar
Cosson, E. et al. Cardiovascular risk prediction is improved by adding asymptomatic coronary status to routine risk assessment in type 2 diabetic patients. Diabetes Care 34, 2101–2107 (2011).
Google Scholar
Cournot, M. et al. Circulating concentrations of redox biomarkers do not improve the prediction of adverse cardiovascular events in patients with Type 2 diabetes mellitus. J Am Heart Assoc 7, e007397 (2018).
Google Scholar
Cox, A. J. et al. Prediction of mortality using a multi-bed vascular calcification score in the Diabetes Heart Study. Cardiovasc. Diabetol. 13, 160 (2014).
Google Scholar
Cox, A. J. et al. Genetic risk score associations with cardiovascular disease and mortality in the Diabetes Heart Study. Diabetes Care 37, 1157–1164 (2014).
Google Scholar
Cox, A. J. et al. Usefulness of biventricular volume as a predictor of mortality in patients with diabetes mellitus (from the Diabetes Heart Study). Am. J. Cardiol. 111, 1152–1158 (2013).
Google Scholar
Cui, N. H., Yang, J. M., Liu, X. & Wang, X. B. Poly(ADP-Ribose) Polymerase activity and coronary artery disease in Type 2 Diabetes mellitus: an observational and bidirectional mendelian randomization study. Arterioscler Thromb. Vasc. Biol. 40, 2516–2526 (2020).
Google Scholar
Daka, B. et al. Low concentrations of serum testosterone predict acute myocardial infarction in men with Type 2 diabetes mellitus. BMC Endocr Disord 15, 35 (2015).
Google Scholar
Davis, T. M., Coleman, R. L. & Holman, R. R. Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83). Diabet Med 31, 200–207 (2014).
Google Scholar
Davis, W. A., Colagiuri, S. & Davis, T. M. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with Type 2 diabetes from the Fremantle Diabetes Study. Med. J. Aust. 190, 180–184 (2009).
Google Scholar
Davis, W. A., Hellbusch, V., Hunter, M. L., Bruce, D. G. & Davis, T. M. E. Contemporary cardiovascular risk assessment for Type 2 diabetes including heart failure as an outcome: The fremantle diabetes study phase ii. J. Clin. Med. 9, 1428 (2020).
Google Scholar
Davis, W. A., Knuiman, M. W. & Davis, T. M. An Australian cardiovascular risk equation for Type 2 diabetes: the Fremantle Diabetes Study. Intern. Med. J. 40, 286–292 (2010).
Google Scholar
Dayan, A. et al. Coronary calcium score, albuminuria and inflammatory markers in Type 2 diabetic patients: associations and prognostic implications. Diabetes Res. Clin. Pract. 98, 98–103 (2012).
Google Scholar
de Galan, B. E. et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with Type 2 diabetes: the action in diabetes and vascular disease: preterax and diamicron modified release controlled evaluation (ADVANCE) trial. Diabetologia 52, 2328–2336 (2009).
Google Scholar
De Lorenzo, A., Lima, R. S., Siqueira-Filho, A. G. & Pantoja, M. R. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am. J. Cardiol. 90, 827–832 (2002).
Google Scholar
de Santiago, A., García-Lledó, A., Ramos, E. & Santiago, C. Prognostic value of ECGs in patients with Type-2 diabetes mellitus without known cardiovascular disease. Rev. Esp. Cardiol. 60, 1035–1041 (2007).
Google Scholar
de Vries, T. I. et al. Normal-range thyroid-stimulating hormone levels and cardiovascular events and mortality in Type 2 diabetes. Diabetes Res. Clin. Pract. 157, 107880 (2019).
Google Scholar
Djaileb, L. et al. Prognostic value of SPECT myocardial perfusion entropy in high-risk Type 2 diabetic patients. Eur. J. Nucl. Med. Mol. Imaging 48, 1813–1821 (2021).
Google Scholar
Doney, A. S. et al. The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with Type 2 diabetes: a genetics of diabetes audit and research study in Tayside Scotland (Go-DARTS) study. Circ. Cardiovasc. Genet. 2, 255–259 (2009).
Google Scholar
Doney, A. S., Lee, S., Leese, G. P., Morris, A. D. & Palmer, C. N. Increased cardiovascular morbidity and mortality in Type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study. Circulation 111, 2927–2934 (2005).
Google Scholar
Doney, A. S. F. et al. Association of common variation in the PPARA gene with incident myocardial infarction in individuals with Type 2 diabetes: A Go-DARTS study. Nuclear Receptor 3, 4 (2005).
Google Scholar
Donnan, P. T., Donnelly, L., New, J. P. & Morris, A. D. Derivation and validation of a prediction score for major coronary heart disease events in a U.K. Type 2 diabetic population. Diabetes Care 29, 1231–1236 (2006).
Google Scholar
Drinkwater, J. J. et al. Retinopathy predicts stroke but not myocardial infarction in Type 2 diabetes: the Fremantle Diabetes Study Phase II. Cardiovasc. Diabetol. 19, 43 (2020).
Google Scholar
Drury, P. L. et al. Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in Type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 54, 32–43 (2011).
Google Scholar
Duan, J. G. et al. Long-term risk of cardiovascular disease among Type 2 diabetic patients with asymptomatic intracranial atherosclerosis: a prospective cohort study. PLoS One 9, e106623 (2014).
Google Scholar
Duan, J. G. et al. Sex differences in epidemiology and risk factors of acute coronary syndrome in Chinese patients with Type 2 diabetes: a long-term prospective cohort study. PLoS One 10, e0122031 (2015).
Google Scholar
Eguchi, K., Hoshide, S. & Kario, K. Target home morning SBP be below 125 mmHg in Type 2 diabetes patients. J. Hypertens. 36, 1284–1290 (2018).
Google Scholar
Eguchi, K. et al. Differential impact of left ventricular mass and relative wall thickness on cardiovascular prognosis in diabetic and nondiabetic hypertensive subjects. Am. Heart J. 154, 79.e79–15 (2007).
Google Scholar
Eguchi, K. et al. Night time blood pressure variability is a strong predictor for cardiovascular events in patients with Type 2 diabetes. Am. J. Hypertens. 22, 46–51 (2009).
Google Scholar
Eguchi, K. et al. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without Type 2 diabetes. Am. J. Hypertens. 21, 443–450 (2008).
Google Scholar
Eguchi, K. et al. Increased heart rate variability during sleep is a predictor for future cardiovascular events in patients with Type 2 diabetes. Hypertens. Res. 33, 737–742 (2010).
Google Scholar
Eijkelkamp, W. B. et al. Renal function and risk for cardiovascular events in Type 2 diabetic patients with hypertension: the RENAAL and LIFE studies. J. Hypertens. 25, 871–876 (2007).
Google Scholar
Eliasson, B. et al. Clinical usefulness of different lipid measures for prediction of coronary heart disease in Type 2 diabetes: a report from the Swedish National Diabetes Register. Diabetes Care 34, 2095–2100 (2011).
Google Scholar
Elkeles, R. S. et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with Type 2 diabetes: the PREDICT study. Eur. Heart J. 29, 2244–2251 (2008).
Google Scholar
Elley, C. R., Kenealy, T., Robinson, E. & Drury, P. L. Glycated haemoglobin and cardiovascular outcomes in people with Type 2 diabetes: a large prospective cohort study. Diabet Med. 25, 1295–1301 (2008).
Google Scholar
Elley, C. R., Robinson, E., Kenealy, T., Bramley, D. & Drury, P. L. Derivation and validation of a new cardiovascular risk score for people with Type 2 diabetes: the new zealand diabetes cohort study. Diabetes Care 33, 1347–1352 (2010).
Google Scholar
Estacio, R. O., Dale, R. A., Schrier, R. & Krantz, M. J. Relation of reduction in urinary albumin excretion to ten-year cardiovascular mortality in patients with Type 2 diabetes and systemic hypertension. Am. J. Cardiol. 109, 1743–1748 (2012).
Google Scholar
Everett, B. M. et al. Troponin and cardiac events in stable ischemic heart disease and diabetes. N. Engl. J. Med. 373, 610–620 (2015).
Google Scholar
Fadini, G. P. et al. p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications. Cardiovasc. Diabetol. 17, 16 (2018).
Google Scholar
Fadini, G. P., Rigato, M., Cappellari, R., Bonora, B. M. & Avogaro, A. Long-term prediction of cardiovascular outcomes by circulating CD34+ and CD34+CD133+ stem cells in patients with Type 2 diabetes. Diabetes Care 40, 125–131 (2017).
Google Scholar
Faghihi-Kashani, S. et al. Fasting hyperinsulinaemia and 2-h glycaemia predict coronary heart disease in patients with Type 2 diabetes. Diabetes Metab. 42, 55–61 (2016).
Google Scholar
Faglia, E. et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care 25, 2032–2036 (2002).
Google Scholar
Ferrarezi, D. A. et al. Allelic variations of the vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease in Type 2 diabetics: the DIABHYCAR prospective study. Diabetes Metab 39, 263–270 (2013).
Google Scholar
Filippella, M. et al. Ankle brachial pressure index usefulness as predictor factor for coronary heart disease in diabetic patients. J. Endocrinol. Invest. 30, 721–725 (2007).
Google Scholar
Florkowski, C. M., Scott, R. S., Coope, P. A. & Moir, C. L. Predictors of mortality from Type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study. Diabetes Res Clin Pract 53, 113–120 (2001).
Google Scholar
Folsom, A. R., Chambless, L. E., Duncan, B. B., Gilbert, A. C. & Pankow, J. S. Prediction of coronary heart disease in middle-aged adults with diabetes. Diabetes Care 26, 2777–2784 (2003).
Google Scholar
Fox, C. S., Sullivan, L., D’Agostino, R. B. Sr & Wilson, P. W. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care 27, 704–708 (2004).
Google Scholar
Fragoso, A., Mendes, F., Silva, A. P. & Neves, P. L. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease. J. Diabetes Complications 29, 1098–1104 (2015).
Google Scholar
Freemantle, N., Danchin, N., Calvi-Gries, F., Vincent, M. & Home, P. D. Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin. Diabetes Obes. Metab. 18, 152–158 (2016).
Google Scholar
Friedman, A. N., Hunsicker, L. G., Selhub, J. & Bostom, A. G. Total plasma homocysteine and arteriosclerotic outcomes in Type 2 diabetes with nephropathy. J. Am. Soc. Nephrol. 16, 3397–3402 (2005).
Google Scholar
Fukushima, H. et al. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. J. Am. Coll. Cardiol. 43, 2219–2224 (2004).
Google Scholar
Fuller, J. H., Stevens, L. K. & Wang, S. L. Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 44, S54–64 (2001).
Google Scholar
Fumisawa, Y. et al. Systematic analysis of risk factors for coronary heart disease in Japanese patients with Type 2 diabetes: a matched case-control study. J. Atheroscler. Thromb. 19, 918–923 (2012).
Google Scholar
Gasior, M. et al. Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention. Cardiol. J. 15, 422–430 (2008).
Google Scholar
Gazzaruso, C. et al. Transcutaneous oxygen tension as a potential predictor of cardiovascular events in Type 2 diabetes: comparison with ankle-brachial index. Diabetes Care 36, 1720–1725 (2013).
Google Scholar
Gazzaruso, C. et al. Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in Type 2 diabetic patients. J. Diabetes Complications 17, 135–140 (2003).
Google Scholar
Gazzaruso, C. et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J. Am. Coll. Cardiol. 51, 2040–2044 (2008).
Google Scholar
Georgoulias, P. et al. Long-term prognostic value of heart-rate recovery after treadmill testing in patients with diabetes mellitus. Int. J. Cardiol. 134, 67–74 (2009).
Google Scholar
Gimeno-Orna, J. A., Lou-Arnal, L. M., Boned-Juliani, B. & Molinero-Herguedas, E. Mild renal insufficiency as a cardiovascular risk factor in non-proteinuric Type II diabetes. Diabetes Res. Clin. Pract. 64, 191–199 (2004).
Google Scholar
Giorda, C. B. et al. Recurrence of cardiovascular events in patients with Type 2 diabetes: epidemiology and risk factors. Diabetes Care 31, 2154–2159 (2008).
Google Scholar
Giovacchini, G. et al. Microalbuminuria predicts silent myocardial ischaemia in Type 2 diabetes patients. Eur. J. Nucl. Med. Mol. Imaging 40, 548–557 (2013).
Google Scholar
Group, T. L. A. R. Prospective Association of GLUL rs10911021 with cardiovascular morbidity and mortality among individuals with Type 2 diabetes: The Look AHEAD Study. Diabetes 65, 297–302, (2015).
Guzder, R. N., Gatling, W., Mullee, M. A. & Byrne, C. D. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed Type 2 diabetes. Diabetologia 49, 49–55 (2006).
Google Scholar
Guzder, R. N., Gatling, W., Mullee, M. A., Mehta, R. L. & Byrne, C. D. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study. Diabet Med 22, 554–562 (2005).
Google Scholar
Hadaegh, F. et al. Electrocardiography-defined silent CHD and risk of cardiovascular events among diabetic patients in a Middle Eastern population. Eur. J. Prev. Cardiol. 19, 1227–1233 (2012).
Google Scholar
Hadjadj, S. et al. Prognostic value of the insertion/deletion polymorphism of the ACE gene in Type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabetes. Diabetes Care 31, 1847–1852 (2008).
Google Scholar
Hage, F. G. et al. The heart rate response to adenosine: a simple predictor of adverse cardiac outcomes in asymptomatic patients with type 2 diabetes. Int. J. Cardiol. 167, 2952–2957 (2013).
Google Scholar
Halon, D. A. et al. Coronary computed tomography (CT) angiography as a predictor of cardiac and noncardiac vascular events in asymptomatic Type 2 diabetics: a 7-year population-based Cohort Study. J. Am. Heart Assoc. 5, e003226 (2016).
Google Scholar
Halon, D. A. et al. Plaque morphology as predictor of late plaque events in patients with asymptomatic Type 2 diabetes. A Long-Term Observational Study. JACC Cardiovasc. Imaging 12, 1353–1363 (2019).
Google Scholar
Hamada, S. & Gulliford, M. C. Multiple risk factor control, mortality and cardiovascular events in Type 2 diabetes and chronic kidney disease: a population-based cohort study. BMJ Open 8, e019950 (2018).
Google Scholar
Hanefeld, M. et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39, 1577–1583 (1996).
Google Scholar
Hata, J. et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with Type 2 diabetes mellitus: the ADVANCE trial. Circulation 128, 1325–1334 (2013).
Google Scholar
Hayashi, T. et al. Metabolic predictors of ischemic heart disease and cerebrovascular attack in elderly diabetic individuals: difference in risk by age. Cardiovasc Diabetol 12, 10 (2013).
Google Scholar
Hayes, A. J., Leal, J., Gray, A. M., Holman, R. R. & Clarke, P. M. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia 56, 1925–1933 (2013).
Google Scholar
He, Q., Pan, J., Wang, L., Fang, Y. & Hu, R. Prospective study: Aldehyde dehydrogenase 2 gene is associated with cardio-cerebrovascular complications in Type 2 diabetes patients. J. Diabetes Investig. 12, 1845–1854 (2021).
Google Scholar
Heidari, B. et al. Assessment of serum 25-hydroxy vitamin D improves coronary heart disease risk stratification in patients with Type 2 diabetes. Am. Heart J. 170, 573–579.e575 (2015).
Google Scholar
Heijmans, B. T. et al. Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects. Atherosclerosis 149, 91–97 (2000).
Google Scholar
Ho, J. S. et al. Association of the PPARG Pro12Ala polymorphism with Type 2 diabetes and incident coronary heart disease in a Hong Kong Chinese population. Diabetes Res. Clin. Pract. 97, 483–491 (2012).
Google Scholar
Hoffmann, M. M., März, W., Genser, B., Drechsler, C. & Wanner, C. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and cardiovascular risk and efficacy of atorvastatin among subjects with diabetes on dialysis: the 4D study. Atherosclerosis 219, 659–662 (2011).
Google Scholar
Hong, L. F. et al. Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease. Lipids Health Dis 16, 7 (2017).
Google Scholar
Howard, B. V. et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arterioscler Thromb Vasc. Biol. 20, 830–835 (2000).
Google Scholar
Hsieh, Y. T. et al. Subnormal estimated glomerular filtration rate strongly predict incident cardiovascular events in Type 2 diabetic chinese population with normoalbuminuria. Medicine (Baltimore) 95, e2200 (2016).
Google Scholar
Hu, C. P. et al. Platelet distribution width on admission predicts in-stent restenosis in patients with coronary artery disease and Type 2 diabetes mellitus treated with percutaneous coronary intervention. Chin. Med. J. (Engl) 131, 757–763 (2018).
Google Scholar
Huang, X. H. et al. Angiotensin-converting enzyme gene polymorphism is associated with coronary heart disease in non-insulin-dependent diabetic patients evaluated for 9 years. Metabolism 47, 1258–1262 (1998).
Google Scholar
Hunt, K. J. et al. Plasma connective tissue growth factor (CTGF/CCN2) levels predict myocardial infarction in the veterans affairs diabetes trial (VADT) Cohort. Diabetes Care 41, 840–846 (2018).
Google Scholar
Iijima, K. et al. Lower physical activity is a strong predictor of cardiovascular events in elderly patients with type 2 diabetes mellitus beyond traditional risk factors: the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int 12, 77–87 (2012).
Google Scholar
Ikeda, Y. et al. Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes. Acta Diabetol. 46, 239–242 (2009).
Google Scholar
Irie, Y. et al. The utility of ultrasonic tissue characterization of carotid plaque in the prediction of cardiovascular events in diabetic patients. Atherosclerosis 230, 399–405 (2013).
Google Scholar
Jeevarethinam, A. et al. Usefulness of carotid plaques as predictors of obstructive coronary artery disease and cardiovascular events in asymptomatic individuals with diabetes mellitus. Am. J. Cardiol. 121, 910–916 (2018).
Google Scholar
Jha, D. et al. Prognostic role of soluble ST2 in acute coronary syndrome with diabetes. Eur. J. Clin. Invest. 48, e12994 (2018).
Google Scholar
Jiang, R. et al. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 27, 1991–1997 (2004).
Google Scholar
Jimenez-Corona, A. et al. Electrocardiographic abnormalities predict deaths from cardiovascular disease and ischemic heart disease in Pima Indians with Type 2 diabetes. Am. Heart J. 151, 1080–1086 (2006).
Google Scholar
Jin, J. L. et al. Triglyceride glucose and haemoglobin glycation index for predicting outcomes in diabetes patients with new-onset, stable coronary artery disease: a nested case-control study. Ann. Med. 50, 576–586 (2018).
Google Scholar
Johnston, S. S. et al. Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with Type 2 diabetes. Diabetes Care 34, 1164–1170 (2011).
Google Scholar
Juutilainen, A., Lehto, S., Suhonen, M., Rönnemaa, T. & Laakso, M. Thoracoabdominal calcifications predict cardiovascular disease mortality in Type 2 diabetic and nondiabetic subjects: 18-year follow-up study. Diabetes Care 33, 583–585 (2010).
Google Scholar
Kamoi, K., Ito, T., Miyakoshi, M. & Minagawa, S. Usefulness of home blood pressure measurement in the morning in patients with type 2 diabetes: long-term results of a prospective longitudinal study. Clin. Exp. Hypertens. 32, 184–192 (2010).
Google Scholar
Katakami, N. et al. Accumulation of oxidative stress-related gene polymorphisms and the risk of coronary heart disease events in patients with Type 2 diabetes–an 8-year prospective study. Atherosclerosis 235, 408–414 (2014).
Google Scholar
Katakami, N. et al. Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients. Cardiovasc. Diabetol. 13, 128 (2014).
Google Scholar
Katakami, N. et al. Ultrasonic tissue characterization of carotid plaque improves the prediction of cardiovascular events in diabetic patients: a pilot study. Diabetes Care 35, 2640–2646 (2012).
Google Scholar
Kawasaki, R. et al. Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan diabetes complications study. Ophthalmology 120, 574–582 (2013).
Google Scholar
Keavney, B. D. et al. UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia 38, 948–952 (1995).
Google Scholar
Keller, T. et al. Prognostic value of high-sensitivity versus conventional cardiac Troponin T assays among patients with Type 2 diabetes mellitus undergoing maintenance hemodialysis. Am. J. Kidney Dis. 71, 822–830 (2018).
Google Scholar
Kenealy, T. et al. An association between ethnicity and cardiovascular outcomes for people with Type 2 diabetes in New Zealand. Diabet. Med. 25, 1302–1308 (2008).
Google Scholar
Kengne, A. P. et al. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax. Diabetologia 53, 821–831 (2010).
Google Scholar
Kengne, A. P. et al. Contemporary model for cardiovascular risk prediction in people with Type 2 diabetes. Eur. J. Cardiovasc. Prev. Rehabil. 18, 393–398 (2011).
Google Scholar
Khalili, S., Hatami, M., Hadaegh, F., Sheikholeslami, F. & Azizi, F. Prediction of cardiovascular events with consideration of general and central obesity measures in diabetic adults: results of the 8.4-year follow-up. Metab. Syndr. Relat. Disord. 10, 218–224 (2012).
Google Scholar
Kim, M. K. et al. Hemoglobin glycation index predicts cardiovascular disease in people with Type 2 diabetes mellitus: A 10-year longitudinal cohort study. J. Diabetes Complications 32, 906–910 (2018).
Google Scholar
Koch, M., Kutkuhn, B., Grabensee, B. & Ritz, E. Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. Nephrol Dial Transplant 12, 2603–2611 (1997).
Google Scholar
Koo, B. K., Chung, W. Y. & Moon, M. K. Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study. Cardiovasc. Diabetol. 19, 82 (2020).
Google Scholar
Kuricová, K. et al. NOS3 894G>T polymorphism is associated with progression of kidney disease and cardiovascular morbidity in Type 2 diabetic patients: NOS3 as a modifier gene for diabetic nephropathy? Kidney Blood Press Res. 38, 92–98 (2013).
Google Scholar
Lagani, V. et al. Development and validation of risk assessment models for diabetes-related complications based on the DCCT/EDIC data. J. Diabetes Complications 29, 479–487 (2015).
Google Scholar
Lapin, B. R. et al. Pain in patients with Type 2 diabetes-related polyneuropathy is associated with vascular events and mortality. J. Clin. Endocrinol. Metab. 105, dgaa394 (2020).
Google Scholar
Lau, K. K. et al. Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with Type 2 diabetes. Cardiovasc. Diabetol. 11, 101 (2012).
Google Scholar
Le Feuvre, C. L. et al. Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with Type 2 diabetes. Diabetes Metab. 31, 135–142 (2005).
Google Scholar
Lee, K. Y. et al. Computed tomography angiography images of coronary artery stenosis provide a better prediction of risk than traditional risk factors in asymptomatic individuals with Type 2 DIABETES: a long-term study of clinical outcomes. Diabetes Care 40, 1241–1248 (2017).
Google Scholar
Lehto, S., Niskanen, L., Suhonen, M., Rönnemaa, T. & Laakso, M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc. Biol. 16, 978–983 (1996).
Google Scholar
Lepojärvi, E. S. et al. Usefulness of highly sensitive troponin as a predictor of short-term outcome in patients with diabetes mellitus and stable coronary artery disease (from the ARTEMIS Study). Am. J. Cardiol. 117, 515–521 (2016).
Google Scholar
Levy, A. P. et al. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. J. Am. Coll. Cardiol. 40, 1984–1990 (2002).
Google Scholar
Li, P. I., Wang, J. N. & Guo, H. R. A long-term quality-of-care score for predicting the occurrence of macrovascular diseases in patients with Type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 139, 72–80 (2018).
Google Scholar
Li, W. P. et al. Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in Type-2 diabetes mellitus. Cardiovasc. Diabetol. 16, 45 (2017).
Google Scholar
Liao, K. M. et al. Risk assessment of macrovascular and microvascular events in patients with Type 2 diabetes by analyzing the amplitude variation of the fourth harmonic component of radial pulse wave. Physiol. Rep. 7, e14252 (2019).
Google Scholar
Lièvre, M. M. et al. Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening. Trials 12, 23 (2011).
Google Scholar
Lim, L. L. et al. Sudomotor dysfunction independently predicts incident cardiovascular-renal events and all-cause death in Type 2 diabetes: the Joint Asia Diabetes Evaluation register. Nephrol. Dial. Transplant 34, 1320–1328 (2019).
Google Scholar
Lim, S. et al. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study. Atherosclerosis 196, 398–404 (2008).
Google Scholar
Lin, C. H., Li, H. Y., Jiang, Y. D., Chang, T. J. & Chuang, L. M. Plasma YKL-40 predicts 10-year cardiovascular and all-cause mortality in individuals with Type 2 diabetes. Clin. Endocrinol. (Oxf) 79, 185–191 (2013).
Google Scholar
Lin, E. H. et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care 33, 264–269 (2010).
Google Scholar
Lin, L. Y. et al. The ankle brachial index exhibits better association with cardiovascular outcomes than interarm systolic blood pressure difference in patients with type 2 diabetes. Medicine (Baltimore) 98, e15556 (2019).
Google Scholar
Linnemann, B. & Janka, H. U. Prolonged QTc interval and elevated heart rate identify the Type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. Exp. Clin. Endocrinol. Diabetes 111, 215–222 (2003).
Google Scholar
Linnemann, B., Voigt, W., Nobel, W. & Janka, H. U. C-reactive protein is a strong independent predictor of death in Type 2 diabetes: association with multiple facets of the metabolic syndrome. Exp. Clin. Endocrinol. Diabetes 114, 127–134 (2006).
Google Scholar
Lopes-Virella, M. F., Hunt, K. J., Baker, N. L., Virella, G. & Moritz, T. The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study. Atherosclerosis 224, 526–531 (2012).
Google Scholar
Lorenzo-Almorós, A. et al. Galectin-3 is associated with cardiovascular events in post-acute coronary syndrome patients with Type-2 diabetes. J. Clin. Med. 9, 1105 (2020).
Google Scholar
Lowe, G. et al. Circulating inflammatory markers and the risk of vascular complications and mortality in people with Type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study. Diabetes 63, 1115–1123 (2014).
Google Scholar
Lu, T. M., Lin, S. J., Lin, M. W., Hsu, C. P. & Chung, M. Y. The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with Type 2 diabetes: a cohort study. Cardiovasc. Diabetol. 10, 16 (2011).
Google Scholar
Lu, W. et al. Non-HDL cholesterol as a predictor of cardiovascular disease in Type 2 diabetes: the strong heart study. Diabetes Care 26, 16–23 (2003).
Google Scholar
Lutgers, H. L. et al. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in Type 2 diabetes mellitus. Diabetologia 52, 789–797 (2009). 1308-9.
Google Scholar
Masi, S. et al. Telomere length, antioxidant status and incidence of ischaemic heart disease in Type 2 diabetes. Int. J. Cardiol. 216, 159–164 (2016).
Google Scholar
Massardo, T. et al. Factors associated with silent myocardial ischemia, autonomic or peripheral neuropathies, and survival in diabetes mellitus type 2 patients without cardiovascular symptoms. Int. J. Diabetes Developing Countries 40, 80–86 (2020).
Google Scholar
McEwan, P., Bennett, H., Ward, T. & Bergenheim, K. Refitting of the UKPDS 68 risk equations to contemporary routine clinical practice data in the UK. Pharmacoeconomics 33, 149–161 (2015).
Google Scholar
McMurray, J. J. et al. Predictors of fatal and nonfatal cardiovascular events in patients with Type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the trial to reduce cardiovascular events with aranesp (darbepoetin-alfa) therapy (TREAT). Am. Heart J. 162, 748–755.e743 (2011).
Google Scholar
Meerwaldt, R. et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 30, 107–112 (2007).
Google Scholar
Mellbin, L. G. et al. Copeptin, IGFBP-1, and cardiovascular prognosis in patients with Type 2 diabetes and acute myocardial infarction: a report from the DIGAMI 2 trial. Diabetes Care 33, 1604–1606 (2010).
Google Scholar
Mentz, R. J. et al. Effect of once-weekly exenatide on clinical outcomes according to baseline risk in patients with Type 2 diabetes mellitus: insights from the EXSCEL trial. J. Am. Heart Assoc. 7, e009304 (2018).
Google Scholar
Mohammedi, K. et al. Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with Type 1 and Type 2 diabetes. Cardiovasc. Diabetol. 14, 845 (2015).
Google Scholar
Mohammedi, K. et al. Absence of peripheral pulses and risk of major vascular outcomes in patients with Type 2 diabetes. Diabetes Care 39, 2270–2277 (2016).
Google Scholar
Monseu, M. et al. Acute kidney injury predicts major adverse outcomes in diabetes: synergic impact with low glomerular filtration rate and albuminuria. Diabetes Care 38, 2333–2340 (2015).
Google Scholar
Moosaie, F. et al. Lp(a) and Apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: A case-cohort study. Nutr. Metab. Cardiovasc. Dis. 30, 1723–1731 (2020).
Google Scholar
Morieri, M. L. et al. Genetic tools for coronary risk assessment in Type 2 diabetes: a Cohort study from the ACCORD clinical trial. Diabetes Care 41, 2404–2413 (2018).
Google Scholar
Morrish, N. J., Stevens, L. K., Fuller, J. H., Jarrett, R. J. & Keen, H. Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO multinational study of vascular disease in diabetics. Diabetologia 34, 590–594 (1991).
Google Scholar
Mukamal, K. J. et al. Prediction and classification of cardiovascular disease risk in older adults with diabetes. Diabetologia 56, 275–283 (2013).
Google Scholar
Nag, S. et al. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years’ data from the South Tees Diabetes Mortality study. Diabet Med. 24, 10–17 (2007).
Google Scholar
Nagamachi, S. et al. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus. J. Nucl. Cardiol. 13, 34–42 (2006).
Google Scholar
Nakamura, M. et al. Brachial-ankle pulse wave velocity as a risk stratification index for the short-term prognosis of Type 2 diabetic patients with coronary artery disease. Hypertens Res. 33, 1018–1024 (2010).
Google Scholar
Nam, G. E. et al. Body weight variability and the risk of cardiovascular outcomes and mortality in patients with Type 2 diabetes: a nationwide Cohort Study. Diabetes Care 43, 2234–2241 (2020).
Google Scholar
Nargesi, A. A. et al. Nonlinear relation between pulse pressure and coronary heart disease in patients with Type 2 diabetes or hypertension. J. Hypertens. 34, 974–980 (2016).
Google Scholar
Nazimek-Siewniak, B., Moczulski, D. & Grzeszczak, W. Risk of macrovascular and microvascular complications in Type 2 diabetes: results of longitudinal study design. J. Diabetes Complications 16, 271–276 (2002).
Google Scholar
Ndrepepa, G. et al. Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease. Clin. Sci. (Lond) 124, 259–268 (2013).
Google Scholar
Nelson, R. G. et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 81, 987–995 (1990).
Google Scholar
Neves, A. L. et al. Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in Type 2 diabetic subjects. Mol. Genet. Metab. 106, 359–365 (2012).
Google Scholar
Nichols, G. A., Joshua-Gotlib, S. & Parasuraman, S. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study. J. Gen. Intern. Med. 28, 691–697 (2013).
Google Scholar
Nilsson, P. M. et al. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register. Eur. J. Cardiovasc. Prev. Rehabil. 16, 506–512 (2009).
Google Scholar
Ningshen, R., Odyuo, Moathung, Arvind, Z., Deba Singh, G. & Devi, T. S. B. A study of QTc interval prolongation as an independent predictor of cardiac mortality in type 2 diabetes mellitus. JMS – J. Med. Soc. 26, 21–25 (2012).
Niskanen, L., Turpeinen, A., Penttilä, I. & Uusitupa, M. I. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. Diabetes Care 21, 1861–1869 (1998).
Google Scholar
Niskanen, L. K., Penttilã, I., Parviainen, M. & Uusitupa, M. I. Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care 19, 486–493 (1996).
Google Scholar
Nitenberg, A. et al. Cardiovascular outcome of patients with abnormal coronary vasomotion and normal coronary arteriography is worse in type 2 diabetes mellitus than in arterial hypertension: a 10 year follow-up study. Atherosclerosis 183, 113–120 (2005).
Google Scholar
Novo-Rodríguez, C. et al. Circulating levels of sclerostin are associated with cardiovascular mortality. PLoS One 13, e0199504 (2018).
Google Scholar
Odeberg, J., Larsson, C. A., Råstam, L. & Lindblad, U. The Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with Type 2 diabetes mellitus. BMC Cardiovasc. Disord 8, 36 (2008).
Google Scholar
Oellgaard, J. et al. Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with Type 2-diabetes and microalbuminuria. J. Diabetes Complications 32, 1133–1140 (2018).
Google Scholar
Oliveira, J. L. et al. Prognostic value of exercise echocardiography in diabetic patients. Cardiovasc. Ultrasound 7, 24 (2009).
Google Scholar
Ong, K. L. et al. The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia 58, 464–473 (2015).
Google Scholar
Ong, K. L. et al. Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study. Diabetes Res. Clin. Pract. 169, 108450 (2020).
Google Scholar
Ortega Moreno, L. et al. Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes. Cardiovasc. Diabetol. 15, 17 (2016).
Google Scholar
Oshima, M. et al. Early change in albuminuria with canagliflozin predicts kidney and cardiovascular outcomes: a post hoc analysis from the CREDENCE trial. J. Am. Soc. Nephrol. 31, 2925–2936 (2020).
Google Scholar
Otto, S. et al. Microembolization and myonecrosis during elective percutaneous coronary interventions in diabetic patients: an intracoronary Doppler ultrasound study with 2-year clinical follow-up. Basic Res. Cardiol. 107, 289 (2012).
Google Scholar
Pagidipati, N. J. et al. Association of obesity with cardiovascular outcomes in patients with Type 2 diabetes and cardiovascular disease: Insights from TECOS. Am. Heart J. 219, 47–57 (2020).
Google Scholar
Panero, F. et al. Uric acid is not an independent predictor of cardiovascular mortality in Type 2 diabetes: a population-based study. Atherosclerosis 221, 183–188 (2012).
Google Scholar
Park, G. M. et al. Coronary computed tomographic angiographic findings in asymptomatic patients with Type 2 diabetes mellitus. Am. J. Cardiol. 113, 765–771 (2014).
Google Scholar
Peng, W. H. et al. Decreased serum esRAGE level is associated with angiographically determined coronary plaque progression in diabetic patients. Clin. Biochem. 42, 1252–1259 (2009).
Google Scholar
Peters, K. E., Chubb, S. A., Davis, W. A. & Davis, T. M. The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study. PLoS One 8, e74355 (2013).
Google Scholar
Petretta, M. et al. Transient ischemic dilation in patients with diabetes mellitus: prognostic value and effect on clinical outcome after coronary revascularization. Circ. Cardiovasc. Imaging 6, 908–915 (2013).
Google Scholar
Pfister, R., Cairns, R., Erdmann, E. & Schneider, C. A. Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study. Diabet. Med. 28, 1206–1212 (2011).
Google Scholar
Pickup, J. C. & Mattock, M. B. Activation of the innate immune system as a predictor of cardiovascular mortality in Type 2 diabetes mellitus. Diabet Med. 20, 723–726 (2003).
Google Scholar
Piniés, J. A. et al. Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complications and Mortality Study risk engine (BASCORE). Diabetologia 57, 2324–2333 (2014).
Google Scholar
Pintó, X. et al. [Factors predictive of cardiovascular disease in patients with type-2 diabetes and hypercholesterolemia. ESODIAH study]. Rev Esp Cardiol 60, 251–258 (2007).
Poon, P. Y., Szeto, C. C., Kwan, B. C., Chow, K. M. & Li, P. K. Relationship between beta1-adrenergic receptor polymorphisms and cardiovascular disease in patients with diabetic nephropathy. Nephrology (Carlton) 15, 242–247 (2010).
Google Scholar
Poon, P. Y., Szeto, C. C., Kwan, B. C., Chow, K. M. & Li, P. K. Relationship between HSP70-2 A+1267G polymorphism and cardiovascular events of Chinese peritoneal dialysis patients. Nephron Clin. Pract. 128, 153–158 (2014).
Google Scholar
Porchay-Baldérelli, I. et al. The CETP TaqIB polymorphism is associated with the risk of sudden death in Type 2 diabetic patients. Diabetes Care 30, 2863–2867 (2007).
Google Scholar
Porchay-Baldérelli, I. et al. Relationships between common polymorphisms of adenosine triphosphate-binding cassette transporter A1 and high-density lipoprotein cholesterol and coronary heart disease in a population with Type 2 diabetes mellitus. Metabolism 58, 74–79 (2009).
Google Scholar
Prentice, J. C., Pizer, S. D. & Conlin, P. R. Identifying the independent effect of HbA1c variability on adverse health outcomes in patients with Type 2 diabetes. Diabetic Med. 33, 1640–1648 (2016).
Google Scholar
Qi, L. et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 54, 1607–1610 (2005).
Google Scholar
Qi, L. et al. Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies. J. Am. Coll. Cardiol. 58, 2675–2682 (2011).
Google Scholar
Qi, L. et al. Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA 310, 821–828 (2013).
Google Scholar
Qi, Q., Workalemahu, T., Zhang, C., Hu, F. B. & Qi, L. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of Type 2 diabetes. Eur. Heart J. 33, 325–334 (2012).
Google Scholar
Qin, Z. et al. The atherogenic index of plasma plays an important role in predicting the prognosis of Type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China. Cardiovasc. Diabetol. 19, 23 (2020).
Google Scholar
Quan, J. et al. Risk prediction scores for mortality, cerebrovascular, and heart disease among Chinese people with Type 2 diabetes. J. Clin. Endocrinol. Metab. 104, 5823–5830 (2019).
Google Scholar
Raghavan, S. et al. Diabetes mellitus-related all-cause and cardiovascular mortality in a National cohort of adults. J. Am. Heart Assoc. 8, e011295 (2019).
Google Scholar
Ramírez-Prado, D. et al. A four-year cardiovascular risk score for Type 2 diabetic inpatients. PeerJ 2015, e984 (2015).
Google Scholar
Rana, B. S. et al. QT interval abnormalities are often present at diagnosis in diabetes and are better predictors of cardiac death than ankle brachial pressure index and autonomic function tests. Heart 91, 44–50 (2005).
Google Scholar
Rasmussen, D. G. K. et al. Higher collagen VI formation is associated with all-cause mortality in patients with Type 2 diabetes and microalbuminuria. Diabetes Care 41, 1493–1500 (2018).
Google Scholar
Ravassa, S. et al. Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with Type 2 diabetes mellitus: a pilot study. Free Radic. Biol. Med. 81, 1–12 (2015).
Google Scholar
Rawshani, A. et al. Risk factors, mortality, and cardiovascular outcomes in patients with Type 2 diabetes. N. Engl. J. Med. 379, 633–644 (2018).
Google Scholar
Rawshani, A. et al. Association between socioeconomic status and mortality, cardiovascular disease, and cancer in patients with Type 2 diabetes. JAMA Intern Med 176, 1146–1154 (2016).
Google Scholar
Read, S. H. et al. Performance of cardiovascular disease risk scores in people diagnosed with Type 2 diabetes: external validation using data from the National Scottish diabetes register. Diabetes Care 41, 2010–2018 (2018).
Google Scholar
Reinhard, H. et al. Osteoprotegerin and mortality in type 2 diabetic patients. Diabetes Care 33, 2561–2566 (2010).
Google Scholar
Resl, M. et al. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus. Diabet. Med. 29, 721–725 (2012).
Google Scholar
Resl, M. et al. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes. Heart 102, 1963–1968 (2016).
Google Scholar
Rossi, M. C. et al. Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study. Diabetes Care 34, 347–352 (2011).
Google Scholar
Rotbain Curovic, V. et al. Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients. Acta Diabetol. 55, 1143–1150 (2018).
Google Scholar
Roumeliotis, A. et al. Carotid intima-media thickness is an independent predictor of all-cause mortality and cardiovascular morbidity in patients with diabetes mellitus Type 2 and chronic kidney disease. Ren Fail 41, 131–138 (2019).
Google Scholar
Roumeliotis, A. K. et al. Association of ALOX12 gene polymorphism with all-cause and cardiovascular mortality in diabetic nephropathy. Int. Urol. Nephrol. 50, 321–329 (2018).
Google Scholar
Roumeliotis, S. et al. Matrix Gla protein T-138C polymorphism is associated with carotid intima media thickness and predicts mortality in patients with diabetic nephropathy. J. Diabetes Complications 31, 1527–1532 (2017).
Google Scholar
Rozing, M. P. et al. Changes in HbA1c during the first six years after the diagnosis of Type 2 diabetes mellitus predict long-term microvascular outcomes. PLoS One 14, e0225230 (2019).
Google Scholar
Ruggenenti, P. et al. Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with Type 2 diabetes. J. Am. Soc. Nephrol. 23, 1717–1724 (2012).
Google Scholar
Russo, G. T. et al. Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study. Acta Diabetol 48, 95–101 (2011).
Google Scholar
Rutter, M. K., Wahid, S. T., McComb, J. M. & Marshall, S. M. Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with Type 2 diabetes. J. Am. Coll. Cardiol. 40, 56–61 (2002).
Google Scholar
Rådholm, K. et al. The impact of using sagittal abdominal diameter to predict major cardiovascular events in European patients with Type 2 diabetes. Nutr. Metab. Cardiovasc. Dis. 27, 418–422 (2017).
Google Scholar
Rørth, R. et al. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes. Eur. J. Heart Fail 21, 40–49 (2019).
Google Scholar
Saely, C. H. et al. The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients. J. Clin. Endocrinol. Metab. 90, 5698–5703 (2005).
Google Scholar
Saely, C. H. et al. Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients. Eur. J. Clin. Invest. 36, 91–97 (2006).
Google Scholar
Saito, I. et al. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann. Intern. Med. 133, 81–91 (2000).
Google Scholar
Sakai, K. et al. Small dense low-density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease. Geriatr. Gerontol. Int. 18, 965–972 (2018).
Google Scholar
Salles, G. F., Leite, N. C., Pereira, B. B., Nascimento, E. M. & Cardoso, C. R. Prognostic impact of clinic and ambulatory blood pressure components in high-risk Type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study. J. Hypertens 31, 2176–2186 (2013).
Google Scholar
Satirapoj, B., Tasanavipas, P. & Supasyndh, O. Role of TCF7L2 and PPARG2 gene polymorphisms in renal and cardiovascular complications among patients with Type 2 diabetes: a Cohort Study. Kidney Dis. 5, 220–227 (2019).
Google Scholar
Saulnier, P. J. et al. Urinary sodium concentration is an independent predictor of all-cause and cardiovascular mortality in a Type 2 diabetes Cohort Population. J. Diabetes Res. 2017, 5327352 (2017).
Google Scholar
Savonitto, S. et al. Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes. Diabetes Vasc. Dis. Res. 15, 14–23 (2018).
Google Scholar
Schimke, K., Chubb, S. A. P., Davis, W. A. & Davis, T. M. E. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in Type 2 diabetes: The Fremantle Diabetes Study. Atherosclerosis 212, 321–326 (2010).
Google Scholar
Schulze, M. B. et al. C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care 27, 889–894 (2004).
Google Scholar
Schulze, M. B. et al. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with Type 2 diabetes. Diabetologia 47, 2129–2136 (2004).
Google Scholar
Scirica, B. M. et al. Prognostic implications of biomarker assessments in patients with Type 2 diabetes at high cardiovascular risk: A secondary analysis of a randomized clinical trial. JAMA Cardiol. 1, 989–998 (2016).
Google Scholar
Scirica, B. M. et al. Cardiovascular outcomes according to urinary albumin and kidney disease in patients with Type 2 diabetes at high cardiovascular risk: observations from the SAVOR-TIMI 53 trial. JAMA Cardiol 3, 155–163 (2018).
Google Scholar
Seferovic, J. P. et al. Retinopathy, neuropathy, and subsequent cardiovascular events in patients with Type 2 diabetes and acute coronary syndrome in the ELIXA: the importance of disease duration. J. Diabetes Res. 2018, 1631263 (2018).
Google Scholar
Seyoum, B., Estacio, R. O., Berhanu, P. & Schrier, R. W. Exercise capacity is a predictor of cardiovascular events in patients with Type 2 diabetes mellitus. Diabetes Vasc. Dis. Res. 3, 197–201 (2006).
Google Scholar
Shao, H., Fonseca, V., Stoecker, C., Liu, S. & Shi, L. Novel risk engine for diabetes progression and mortality in USA: building, relating, assessing, and validating outcomes (BRAVO). Pharmacoeconomics 36, 1125–1134 (2018).
Google Scholar
Shao, H., Shi, L. & Fonseca, V. A. Using the BRAVO risk engine to predict cardiovascular outcomes in clinical trials with sodium-glucose transporter 2 inhibitors. Diabetes Care 43, 1530–1536 (2020).
Google Scholar
Sharma, A. et al. Causes of death in a contemporary Cohort of Patients With Type 2 diabetes and atherosclerotic cardiovascular disease: insights from the TECOS trial. Diabetes Care 40, 1763–1770 (2017).
Google Scholar
Sharma, A. et al. Clinical and biomarker predictors of expanded heart failure outcomes in patients with Type 2 diabetes mellitus after a recent acute coronary syndrome: insights from the EXAMINE Trial. J. Am. Heart Assoc. 9, e012797 (2020).
Google Scholar
Shin, S. H. et al. Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with Type 2 diabetes and a recent acute coronary syndrome. Eur. J. Heart Fail. 22, 1133–1143 (2020).
Google Scholar
Siddique, A. et al. Relationship of mildly increased albuminuria and coronary artery revascularization outcomes in patients with diabetes. Catheter Cardiovasc. Interv. 93, E217–e224 (2019).
Google Scholar
Sidorenkov, G., Voorham, J., de Zeeuw, D., Haaijer-Ruskamp, F. M. & Denig, P. Do treatment quality indicators predict cardiovascular outcomes in patients with diabetes? PLoS One 8, e78821 (2013).
Google Scholar
Silva, A. P. et al. Phosphorus as an early marker of morbidity and mortality in Type 2 chronic kidney disease diabetic patients. J. Diabetes Complications 27, 328–332 (2013).
Google Scholar
Silva, A. P. et al. What is the role of apelin regarding cardiovascular risk and progression of renal disease in Type 2 diabetic patients with diabetic nephropathy? Biomed. Res. Int. 2013, 247649 (2013).
Google Scholar
Simmons, R. K. et al. Performance of the UK prospective diabetes study risk engine and the Framingham risk equations in estimating cardiovascular disease in the EPIC- Norfolk Cohort. Diabetes Care 32, 708–713 (2009).
Google Scholar
Smáradóttir, M. I. et al. Copeptin and insulin-like growth factor binding protein-1 during follow-up after an acute myocardial infarction in patients with type 2 diabetes: a report from the diabetes mellitus insulin-glucose infusion in acute myocardial infarction 2 cohort. Diab. Vasc. Dis. Res. 16, 22–27 (2019).
Google Scholar
So, W. Y. et al. Aldose reductase genotypes and cardiorenal complications: an 8-year prospective analysis of 1074 Type 2 diabetic patients. Diabetes Care 31, 2148–2153 (2008).
Google Scholar
Soejima, H. et al. Proteinuria is independently associated with the incidence of primary cardiovascular events in diabetic patients. J. Cardiol. 75, 387–393 (2020).
Google Scholar
Soinio, M., Marniemi, J., Laakso, M., Lehto, S. & Rönnemaa, T. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with Type 2 diabetes mellitus. Ann. Intern. Med. 140, 94–100, (2004).
Google Scholar
Sone, H. et al. Waist circumference as a cardiovascular and metabolic risk in Japanese patients with Type 2 diabetes. Obesity (Silver Spring) 17, 585–592 (2009).
Google Scholar
Sone, H. et al. Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with Type 2 diabetes: subanalysis of the Japan Diabetes Complications Study. Diabetes Care 35, 1150–1157 (2012).
Google Scholar
Sone, H. et al. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with Type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). J. Clin. Endocrinol. Metab. 96, 3448–3456 (2011).
Google Scholar
Sone, H. et al. Leisure-time physical activity is a significant predictor of stroke and total mortality in Japanese patients with Type 2 diabetes: analysis from the Japan Diabetes Complications Study (JDCS). Diabetologia 56, 1021–1030 (2013).
Google Scholar
Spoelstra-de Man, A. M., Brouwer, C. B., Stehouwer, C. D. & Smulders, Y. M. Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with Type 2 diabetes and microalbuminuria. Diabetes Care 24, 2097–2101 (2001).
Google Scholar
Standl, E. et al. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia 39, 1540–1545 (1996).
Google Scholar
Stehouwer, C. D., Gall, M. A., Hougaard, P., Jakobs, C. & Parving, H. H. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria. Kidney Int 55, 308–314 (1999).
Google Scholar
Stevens, R. J., Kothari, V., Adler, A. I. & Stratton, I. M. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin. Sci. (Lond) 101, 671–679 (2001).
Google Scholar
Strojek, K. et al. Factors associated with cardiovascular events in patients with Type 2 diabetes and acute myocardial infarction. J. Clin. Endocrinol. Metab. 101, 243–253 (2016).
Google Scholar
Sultan, A. et al. Myocardial perfusion imaging and cardiac events in a cohort of asymptomatic patients with diabetes living in southern France. Diabet. Med. 23, 410–418 (2006).
Google Scholar
Svendstrup, M., Christiansen, M. S., Magid, E., Hommel, E. & Feldt-Rasmussen, B. Increased orosomucoid in urine is an independent predictor of cardiovascular and all-cause mortality in patients with Type 2 diabetes at 10 years of follow-up. J. Diabetes Complications 27, 570–575 (2013).
Google Scholar
Svensson, E. et al. Early glycemic control and magnitude of HbA(1c) reduction predict cardiovascular events and mortality: population-based Cohort Study of 24,752 metformin initiators. Diabetes Care 40, 800–807 (2017).
Google Scholar
Svensson, M. K., Cederholm, J., Eliasson, B., Zethelius, B. & Gudbjörnsdottir, S. Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with Type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register. Diab. Vasc. Dis. Res. 10, 520–529 (2013).
Google Scholar
Takao, T., Suka, M., Yanagisawa, H. & Iwamoto, Y. Impact of postprandial hyperglycemia at clinic visits on the incidence of cardiovascular events and all-cause mortality in patients with Type 2 diabetes. J. Diabetes Investig. 8, 600–608 (2017).
Google Scholar
Tan, X. & Benedict, C. Increased risk of myocardial infarction among patients with type 2 diabetes who carry the common rs10830963 variant in the MTNR1B gene. Diabetes Care 43, 2289–2292 (2020).
Google Scholar
Tanaka, S. et al. Predicting macro- and microvascular complications in Type 2 diabetes: the Japan diabetes complications study/the Japanese elderly diabetes intervention trial risk engine. Diabetes Care 36, 1193–1199 (2013).
Google Scholar
Thanyasiri, P., Celermajer, D. S. & Adams, M. R. Predictors of long-term outcome following percutaneous coronary intervention in patients with type 2 diabetes mellitus. Coron Artery Dis 17, 131–138 (2006).
Google Scholar
The Look, A. R. G. Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial. Diabetologia 58, 1803–1813 (2015).
Google Scholar
Theilade, S. et al. Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia–the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT). J. Hum. Hypertens. 30, 46–52 (2016).
Google Scholar
Thomas, M. C. et al. Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial. J. Am. Heart Assoc. 7, e008226 (2018).
Google Scholar
Tian, P., Zheng, X., Li, M., Li, W. & Niu, Q. Long-term prognostic value of coronary computed tomography angiography for asymptomatic patients with cad in type 2 diabetes mellitus. Exp. Therap. Med. 18, 747–754 (2019).
Google Scholar
Ting, R. Z. et al. Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study. Cardiovasc. Diabetol. 9, 77 (2010).
Google Scholar
Tobias, D. K. et al. Circulating branched-chain amino acids and incident cardiovascular disease in a prospective Cohort of US women. Circ. Genom. Precis. Med. 11, e002157 (2018).
Google Scholar
Turner, R. C. et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 316, 823–828 (1998).
Google Scholar
Twito, O. et al. New-onset diabetes in elderly subjects: association between HbA1c levels, mortality, and coronary revascularization. Diabetes Care 36, 3425–3429 (2013).
Google Scholar
Umamahesh, K., Vigneswari, A., Surya Thejaswi, G., Satyavani, K. & Viswanathan, V. Incidence of cardiovascular diseases and associated risk factors among subjects with type 2 diabetes – an 11-year follow up study. Indian Heart J. 66, 5–10 (2014).
Google Scholar
Valmadrid, C. T., Klein, R., Moss, S. E. & Klein, B. E. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch. Intern. Med. 160, 1093–1100 (2000).
Google Scholar
Valoti, E. et al. Impact of a complement factor H Gene variant on renal dysfunction, cardiovascular events, and response to ACE inhibitor therapy in Type 2 diabetes. Front Genet 10, 681 (2019).
Google Scholar
van der Heijden, A. A., Ortegon, M. M., Niessen, L. W., Nijpels, G. & Dekker, J. M. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study. Diabetes Care 32, 2094–2098 (2009).
Google Scholar
van der Leeuw, J. et al. Novel biomarkers to improve the prediction of cardiovascular event risk in Type 2 diabetes mellitus. J. Am. Heart Assoc. 5, e003048 (2016).
Google Scholar
van der Leeuw, J. et al. The validation of cardiovascular risk scores for patients with Type 2 diabetes mellitus. Heart 101, 222–229 (2015).
Google Scholar
Vanzetto, G. et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 22, 19–26 (1999).
Google Scholar
Vavruch, C. et al. Using proximity extension proteomics assay to discover novel biomarkers associated with circulating leptin levels in patients with Type 2 diabetes. Sci. Rep. 10, 13097 (2020).
Google Scholar
Velho, G. et al. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of Type 2 diabetes. Cardiovasc. Diabetol. 17, 110 (2018).
Google Scholar
Vengen, I. T., Dale, A. C., Wiseth, R., Midthjell, K. & Videm, V. Lactoferrin is a novel predictor of fatal ischemic heart disease in diabetes mellitus type 2: long-term follow-up of the HUNT 1 study. Atherosclerosis 212, 614–620 (2010).
Google Scholar
Venskutonyte, L., Brismar, K., Öhrvik, J., Rydén, L. & Kjellström, B. Self-rated health predicts outcome in patients with Type 2 diabetes and myocardial infarction: a DIGAMI 2 quality of life sub-study. Diab. Vasc. Dis. Res. 10, 361–367 (2013).
Google Scholar
Venskutonyte, L., Malmberg, K., Norhammar, A., Wedel, H. & Rydén, L. Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes. J. Intern. Med. 268, 75–82 (2010).
Google Scholar
Venuraju, S. M. et al. Duration of Type 2 diabetes mellitus and systolic blood pressure as determinants of severity of coronary stenosis and adverse events in an asymptomatic diabetic population: PROCEED study. Cardiovasc. Diabetol. 18, 51 (2019).
Google Scholar
Venuraju, S. M. et al. Association of epicardial fat volume with the extent of coronary atherosclerosis and cardiovascular adverse events in asymptomatic patients with diabetes. Angiology 72, 442–450 (2021).
Google Scholar
Venäläinen, M. S., Klén, R., Mahmoudian, M., Raitakari, O. T. & Elo, L. L. Easy-to-use tool for evaluating the elevated acute kidney injury risk against reduced cardiovascular disease risk during intensive blood pressure control. J. Hypertens. 38, 511–518 (2020).
Google Scholar
Vepsäläinen, T. et al. Proteinuria modifies the effect of systolic blood pressure on total and cardiovascular disease mortality in patients with type 2 diabetes. J. Intern. Med. 272, 611–619 (2012).
Google Scholar
von Scholten, B. J. et al. Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with Type 2 diabetes. Cardiovasc. Diabetol. 14, 59 (2015).
Google Scholar
von Scholten, B. J. et al. Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in Type 2 diabetic patients with microalbuminuria. Diabetologia 59, 1549–1557 (2016).
Google Scholar
von Scholten, B. J. et al. Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria. J Diabetes Complications 30, 248–255 (2016).
Google Scholar
Wallander, M. et al. IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes. Diabetes Care 30, 2343–2348 (2007).
Google Scholar
Wan, E. Y., Fong, D. Y., Fung, C. S. & Lam, C. L. Incidence and predictors for cardiovascular disease in Chinese patients with Type 2 diabetes mellitus – a population-based retrospective cohort study. J. Diabetes Complications 30, 444–450 (2016).
Google Scholar
Wan, E. Y. F. et al. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with Type 2 diabetes mellitus: A population-based retrospective cohort study. Diabetes Obes. Metab. 20, 309–318 (2018).
Google Scholar
Wang, Y. et al. Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and beta-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes–an 8-year prospective cohort analysis of 1297 patients. Diabet Med. 27, 376–383 (2010).
Google Scholar
Wang, Y. et al. Prognostic effect of insertion/deletion polymorphism of the ace gene on renal and cardiovascular clinical outcomes in Chinese patients with Type 2 diabetes. Diabetes Care 28, 348–354 (2005).
Google Scholar
Watson, C. et al. Investigation of association of genetic variant rs3918242 of matrix metalloproteinase-9 with hypertension, myocardial infarction and progression of ventricular dysfunction in Irish Caucasian patients with diabetes: a report from the STOP-HF follow-up prog. BMC Cardiovasc. Disord. 21, 87 (2021).
Google Scholar
Wei, M., Gaskill, S. P., Haffner, S. M. & Stern, M. P. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21, 1167–1172 (1998).
Google Scholar
Wells, B. J. et al. Prediction of morbidity and mortality in patients with Type 2 diabetes. PeerJ 2013, e87 (2013).
Google Scholar
Wijkman, M., Länne, T., Östgren, C. J. & Nystrom, F. H. Aortic pulse wave velocity predicts incident cardiovascular events in patients with type 2 diabetes treated in primary care. J. Diabetes Complications 30, 1223–1228 (2016).
Google Scholar
Wijkman, M., Länne, T., Östgren, C. J. & Nystrom, F. H. Diastolic orthostatic hypertension and cardiovascular prognosis in Type 2 diabetes: a prospective cohort study. Cardiovasc. Diabetol. 15, 83 (2016).
Google Scholar
Winkler, K. et al. Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with Type 2 diabetes mellitus. Atherosclerosis 208, 197–202 (2010).
Google Scholar
Wolsk, E. et al. Role of B-Type natriuretic peptide and N-Terminal prohormone BNP as predictors of cardiovascular morbidity and mortality in patients with a recent coronary event and Type 2 diabetes mellitus. J. Am. Heart Assoc. 6, e004743 (2017).
Google Scholar
Wong, Y. K. et al. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus. Cardiovasc. Diabetol. 18, 171 (2019).
Google Scholar
Woodward, M. et al. Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score. Diabetes Obes. Metab. 18, 289–294 (2016).
Google Scholar
Yamada, T., Itoi, T., Kiuchi, Y., Nemoto, M. & Yamashita, S. Proliferative diabetic retinopathy is a predictor of coronary artery disease in Japanese patients with type 2 diabetes. Diabetes Res. Clin. Pract. 96, e4–6 (2012).
Google Scholar
Yamasaki, Y. et al. Carotid intima-media thickness in Japanese Type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 23, 1310–1315 (2000).
Google Scholar
Yang, F., Ye, J., Pomerantz, K. & Stewart, M. Potential modification of the UKPDS risk engine and evaluation of macrovascular event rates in controlled clinical trials. Diabetes, Metab. Syndrome Obesity: Targets Ther. 6, 247–256 (2013).
Google Scholar
Yang, G. R. et al. Association between neck circumference and the occurrence of cardiovascular events in Type 2 diabetes: Beijing Community Diabetes Study 20 (BCDS-20). Biomed. Res. Int. 2019, 4242304 (2019).
Google Scholar
Yang, S. H. et al. Triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular events in diabetics with coronary artery disease. Am. J. Med. Sci. 354, 117–124 (2017).
Google Scholar
Yang, S. H. et al. Serum fibrinogen and cardiovascular events in Chinese patients with Type 2 diabetes and stable coronary artery disease: a prospective observational study. BMJ Open 7, e015041 (2017).
Google Scholar
Yang, X. et al. Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients – the Hong Kong diabetes registry. Cardiovasc. Diabetol. 6, 37 (2007).
Google Scholar
Yang, X. et al. Development and validation of a total coronary heart disease risk score in Type 2 diabetes mellitus. Am. J. Cardiol. 101, 596–601 (2008).
Google Scholar
Yang, Z. K. et al. Elevated glycated albumin and reduced endogenous secretory receptor for advanced glycation endproducts levels in serum predict major adverse cardio-cerebral events in patients with Type 2 diabetes and stable coronary artery disease. Int. J. Cardiol. 197, 241–247 (2015).
Google Scholar
Yeboah, J. et al. Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Atherosclerosis 236, 411–417 (2014).
Google Scholar
Yeboah, P., Hsu, F. C., Bertoni, A. G. & Yeboah, J. Body mass index, change in weight, body weight variability and outcomes in Type 2 diabetes mellitus (from the ACCORD Trial). Am. J. Cardiol. 123, 576–581 (2019).
Google Scholar
Yiu, K. H. et al. Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus. Cardiovasc. Diabetol. 13, 63 (2014).
Google Scholar
Yoshida, M. et al. Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with Type 2 diabetes. Diabetes Care 35, 178–180 (2012).
Google Scholar
Yoshimura, T. et al. Low blood flow estimates in lower-leg arteries predict cardiovascular events in Japanese patients with Type 2 diabetes with normal ankle-brachial indexes. Diabetes Care 29, 1884–1890 (2006).
Google Scholar
Young, J. B. et al. Development of predictive risk models for major adverse cardiovascular events among patients with Type 2 diabetes mellitus using health insurance claims data. Cardiovasc. Diabetol. 17, 118 (2018).
Google Scholar
Yu, D. et al. Development and external validation of risk scores for cardiovascular hospitalization and rehospitalization in patients with diabetes. J. Clin. Endocrinol. Metab. 103, 1122–1129 (2018).
Google Scholar
Yu, D. et al. Total/high density lipoprotein cholesterol and cardiovascular disease (re)hospitalization nadir in type 2 diabetes. J. Lipid Res. 59, 1745–1750 (2018).
Google Scholar
Yu, D. et al. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with Type 2 diabetes and incident diabetic nephropathy: prospective cohort study. BMJ Open Diabetes Res Care 7, e000735 (2019).
Google Scholar
Yu, D. & Simmons, D. Relationship between HbA1c and risk of all-cause hospital admissions among people with Type 2 diabetes. Diabetic Medicine 30, 1407–1411 (2013).
Google Scholar
Yu, D. & Simmons, D. Association between blood pressure and risk of cardiovascular hospital admissions among people with type 2 diabetes. Heart 100, 1444–1449 (2014).
Google Scholar
Yun, J. S., Park, Y. M., Cha, S. A., Ahn, Y. B. & Ko, S. H. Progression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes. Cardiovasc. Diabetol. 17, 109 (2018).
Google Scholar
Zafrir, B. et al. Low cardiorespiratory fitness and coronary artery calcification: Complementary cardiovascular risk predictors in asymptomatic Type 2 diabetics. Atherosclerosis 241, 634–640 (2015).
Google Scholar
Zafrir, B. et al. Resting heart rate and measures of effort-related cardiac autonomic dysfunction predict cardiovascular events in asymptomatic type 2 diabetes. Eur. J. Prev. Cardiol. 23, 1298–1306 (2016).
Google Scholar
Zethelius, B. et al. A new model for 5-year risk of cardiovascular disease in Type 2 diabetes, from the Swedish National Diabetes Register (NDR). Diabetes Res. Clin. Pract. 93, 276–284 (2011).
Google Scholar
Zhang, C. et al. Genetic variation in the hepatic lipase gene and the risk of coronary heart disease among US diabetic men: potential interaction with obesity. Diabetologia 49, 1552–1559 (2006).
Google Scholar
Zhang, X. L. et al. Improved framingham risk scores of patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year prospective study of the effects of multifactorial interventions on cardiovascular risk factors (The Beijing Communities Diabetes Study 22). Diabetes Therapy 11, 885–903 (2020).
Google Scholar
Zhao, Q. et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc. Diabetol. 19, 108 (2020).
Google Scholar
Zhou, J. B. et al. Prediction of proliferative diabetic retinopathy to asymptomatic obstructive coronary artery disease in Chinese Type 2 diabetes individuals: an exploratory study. Metab. Syndr. Relat. Disord. 17, 367–373 (2019).
Google Scholar
Zimering, M. B., Anderson, R. J., Ge, L. & Moritz, T. E. Increased plasma basic fibroblast growth factor is associated with coronary heart disease in adult type 2 diabetes mellitus. Metabolism 60, 284–291 (2011).
Google Scholar
Zimering, M. B., Anderson, R. J., Ge, L., Moritz, T. E. & Duckworth, W. C. Basic fibroblast growth factor predicts cardiovascular disease occurrence in participants from the veterans affairs diabetes trial. Fronti. Endocrinol. 4, 183 (2013).
Zobel, E. H. et al. Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria. Diabetologia 60, 1883–1891 (2017).
Google Scholar
Zoppini, G. et al. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction. Atherosclerosis 212, 287–291 (2010).
Google Scholar
Østergaard, H. B. et al. Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients. Diabetes Metab. 45, 254–260 (2019).
Google Scholar
Fitipaldi, H. hugofitipaldi/T2DCVD_Prognostics: T2DCVD-Prognostics Shiny app. Zenodo, (2023).
Fitipaldi, H. & Franks, P. W. Ethnic, gender and other sociodemographic biases in genome-wide association studies for the most burdensome non-communicable diseases: 2005-2022. Hum. Mol. Genet. 32, 520–532 (2023).
Google Scholar
Misra, S. et al. Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study. Lancet Diabetes Endocrinol. 9, 671–680 (2021).
Google Scholar
Di Angelantonio, E. et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 120, 2177–2187 (2009).
Google Scholar
Tam, C. H. T. et al. Identification of a common variant for coronary heart disease at PDE1A contributes to individualized treatment goals and risk stratification of cardiovascular complications in Chinese patients with Type 2 diabetes. Diabetes Care 46, 1271–1281 (2023).
Google Scholar
Chan, J. et al. The Joint Asia Diabetes Evaluation (JADE) Program: a web-based program to translate evidence to clinical practice in Type 2 diabetes. Diabet Med. 26, 693–699 (2009).
Google Scholar
Chan, J. C. N. et al. Effect of a web-based management guide on risk factors in patients with Type 2 diabetes and diabetic kidney disease: A JADE randomized clinical trial. JAMA Netw. Open 5, e223862 (2022).
Google Scholar
Lim, L. L. et al. Association of technologically assisted integrated care with clinical outcomes in Type 2 diabetes in Hong Kong using the prospective JADE program: a retrospective cohort analysis. PLoS Med. 17, e1003367 (2020).
Google Scholar
Chan, J. C. et al. Effects of telephone-based peer support in patients with type 2 diabetes mellitus receiving integrated care: a randomized clinical trial. JAMA Intern Med. 174, 972–981 (2014).
Google Scholar
Lim, L. L. et al. Effects of a technology-assisted integrated diabetes care program on cardiometabolic risk factors among patients with Type 2 Diabetes in the Asia-Pacific Region: the JADE program randomized clinical trial. JAMA Netw. Open 4, e217557 (2021).
Google Scholar
link